V
Viracta Therapeutics (VIRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Viracta Therapeutics (VIRX)
Viracta Therapeutics, Inc., formerly Sunesis Pharmaceuticals, Inc., is a precision oncology company. The Company is focused on the development of new medicines targeting virus-associated malignancies. The Company conducts clinical trials for its comb... Read more
- USD0.80
- USD0.81
- USD0.80
- USD2.38
- -25.70%
- --
- 15.24k
- 124.10k
- 32M
- 0.43
- -28.30%
Stock News
2 hours ago
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2024 CONFERENCE CALL
Yahoo
3 hours ago
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
Yahoo
3 hours ago
Dynatrace to Present at Upcoming Investor Conferences
Yahoo
3 hours ago
Zebra Technologies Unveils New Solutions at Automate 2024, Advancing the Connected Factory
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
